Jincheng Pharmaceuticals (300233.SZ) subsidiary receives European Pharmacopoeia certificate of suitability for glutathione API.

date
18/11/2025
Guan, the WeChat Finance APP News, Jincheng Pharmaceutical (300233.SZ) announced that its wholly-owned subsidiary Shandong Jincheng Biopharmaceutical Co., Ltd. (hereinafter referred to as "Jincheng Biopharmaceutical") recently received the European Pharmacopoeia (EP) Certificate of Suitability for Glutathione API issued by the European Medicines Quality Agency (EDQM).